Ultra-performance liquid chromatography and time-of-flight mass spectrometry analysis of ginsenoside metabolites in human plasma

American Journal of Chinese Medicine

Volumn 39, Issue 6, 2011, Pages 1161-1171

  Wang, Chong Zhi ^a,b   Kim, Karen E ^c   Du, Guang Jian ^a,b   Qi, Lian Wen ^a,b,d   Wen, Xiao Dong ^a,b,d   Li, Ping ^d   Bauer, Brent A ^a,b   Bissonnette, Marc B ^c   Musch, Mark W ^c   Chang, Eugene B ^c   Yuan, Chun Su ^a,b,c  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

American Ginseng; Compound K; Ginsenoside Rb1; Human Plasma Concentration; Microbiota Metabolism; Panax quinquefolius; UPLC TOF MS Analysis

Indexed keywords

20 GINSENOSIDE RG2; 20 GINSENOSIDE RG3; COMPOUND K; DIGOXIN; DRUG METABOLITE; GINSENG EXTRACT; GINSENOSIDE; GINSENOSIDE RB 1; GINSENOSIDE RB 3; GINSENOSIDE RC; GINSENOSIDE RD; GINSENOSIDE RE; GINSENOSIDE RG 1; GINSENOSIDE RG 2; GINSENOSIDE RG 3; GINSENOSIDE RH 1; GINSENOSIDE RH 2; PSEUDOGINSENOSIDE; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DETERMINATION; FEMALE; GINSENG; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PLANT ROOT; PLASMA; POWDER; SINGLE DRUG DOSE; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ADMINISTRATION, ORAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GINSENOSIDES; HUMANS; INTESTINES; MALE; MASS SPECTROMETRY; PANAX;

EID: 81155138954     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X11009470     Document Type: Article

References (28)

1. Andrade, A.S., C. Hendrix, T.L. Parsons, B. Caballero, C.S. Yuan, C.W. Flexner, A.S. Dobs and T.T. Brown. Pharmacokinetic and metabolic effects of American ginseng (Panax quinquefo-lius) in healthy volunteers receiving the HIV protease inhibitor indinavir. BMC Complement. Altern. Med. 8: 50, 2008.
2. Ang-Lee, M.K., J. Moss and C.S. Yuan. Herbal medicines and perioperative care. JAMA 286: 208-216, 2001.
3. Attele, A.S., J.A. Wu and C.S. Yuan. Ginseng pharmacology: multiple constituents and multiple actions. Biochem. Pharmacol. 58: 1685-1693, 1999.
4. Christensen, L.P. Ginsenosides chemistry, biosynthesis, analysis, and potential health effects. Adv. Food Nutr. Res. 55: 1-99, 2009.
5. Dan, M., M.M. Su, X.F. Gao, T. Zhao, A.H. Zhao, G.X. Xie, Y.P. Qiu, M.M. Zhou, Z. Liu and W. Jia. Metabolite profiling of Panax notoginseng using UPLC-ESI-MS. Phytochemistry 69: 2237-2244, 2008.
6. Guengerich, F.P. and S. Rendic. Update information on drug metabolism systems -2009, part I. Curr. Drug Metab. 11: 1-3, 2010.
7. Guillarme, D., J. Schappler, S. Rudaz and J.L. Veuthey. Coupling ultra-high-pressure liquid chro-matography with mass spectrometry. Trends Anal. Chem. 29: 15-27, 2010.
8. Hasegawa, H. Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid. J. Pharmacol. Sci. 95: 153-157, 2004.
9. Jang, H.I. and H.M. Shin. Wild Panax ginseng (Panax ginseng C.A. Meyer) protects against methotrexate-induced cell regression by enhancing the immune response in RAW 264.7 macrophages. Am. J. Chin. Med. 38: 949-960, 2010.
10. Kim, J.J., H. Xiao, Y. Tan, Z.Z. Wang, J. Paul Seale and X. Qu. The effects and mechanism of saponins of Panax notoginseng on glucose metabolism in 3T3-L1 cells. Am. J. Chin. Med. 37: 1179-1189, 2009.
11. Kong, H., M. Wang, K. Venema, A. Maathuis, R. van der Heijden, J. van der Greef, G. Xu and T. Hankemeier. Bioconversion of red ginseng saponins in the gastro-intestinal tract in vitro model studied by high-performance liquid chromatography-high resolution Fourier transform ion cyclotron resonance mass spectrometry. J. Chromatogr. A 1216: 2195-2203, 2009.
12. Laparra, J.M. and Y. Sanz. Interactions of gut microbiota with functional food components and nutraceuticals. Pharmacol. Res. 61: 219-225, 2010.
13. Lee, L.S., S.D. Wise, C. Chan, T.L. Parsons, C. Flexner and P.S. Lietman. Possible differential induction of phase 2 enzyme and antioxidant pathways by american ginseng, Panax quin-quefolius. J. Clin. Pharmacol. 48: 599-609, 2008.
14. Li, L., G.A. Luo, Q.L. Liang, P. Hu and Y.M. Wang. Rapid qualitative and quantitative analyses of Asian ginseng in adulterated American ginseng preparations by UPLC/Q-TOF-MS. J. Pharm. Biomed. Anal. 52: 66-72, 2010a.
15. Li, S.L., S.F. Lai, J.Z. Song, C.F. Qiao, X. Liu, Y. Zhou, H. Cai, B.C. Cai and H.X. Xu. Decocting-induced chemical transformations and global quality of Du-Shen-Tang, the decoction of ginseng evaluated by UPLC-Q-TOF-MS/MS based chemical profiling approach. J. Pharm. Biomed. Anal. 53: 946-957, 2010b.
16. Li, X.T., R. Chen, L.M. Jin and H.Y. Chen. Regulation on energy metabolism and protection on mitochondria of Panax ginseng polysaccharide. Am. J. Chin. Med. 37: 1139-1152, 2009.
17. Lin, W.N., H.Y. Lu, M.S. Lee, S.Y. Yang, H.J. Chen, Y.S. Chang and W.T. Chang. Evaluation of the cultivation age of dried ginseng radix and its commercial products by using (1)H-NMR fingerprint analysis. Am. J. Chin. Med. 38: 205-218, 2010.
18. Liu, H.F., J.L. Yang, F.F. Du, X.M. Gao, X.T. Ma, Y.H. Huang, F. Xu, W. Niu, F.Q. Wang, Y. Mao, Y. Sun, T. Lu, C.X. Liu, B.L. Zhang and C. Li. Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats. Drug Metab. Dispos. 37: 2290-2298, 2009.
19. Muth, D., E. Marsden-Edwards, P. Kachlicki and M. Stobiecki. Differentiation of isomeric mal-onylated flavonoid glyconjugates in plant extracts with UPLC-ESI/MS/MS. Phytochem. Anal. 19: 444-452, 2008.
20. Ng, T.B. Pharmacological activity of sanchi ginseng (Panax notoginseng). J. Pharm. Pharmacol. 58: 1007-1019, 2006.
21. Paek, I.P., Y. Moon, J. Kim, H.Y. Ji, S.A. Kim, D.H. Sohn, J.B. Kim and H.S. Lee. Pharmacokinetics of a ginseng saponin metabolite compound K in rats. Biopharm. Drug Dispos. 27: 39-45, 2006.
22. Qi, L.W., C.Z. Wang and C.S. Yuan. Ginsenosides from American ginseng: chemical and pharmacological diversity. Phytochemistry 72: 689-699, 2011a.
23. Qi, L.W., C.Z. Wang and C.S. Yuan. Isolation and analysis of ginseng: advances and challenges. Nat. Prod. Rep. 28: 467-495, 2011b.
24. Taira, S., R. Ikeda, N. Yokota, I. Osaka, M. Sakamoto, M. Kato and Y. Sahashi. Mass spectrometric imaging of ginsenosides localization in Panax ginseng root. Am. J. Chin. Med. 38: 485-493, 2010.
25. Tawab, M.A., U. Bahr, M. Karas, M. Wurglics and M. Schubert-Zsilavecz. Degradation of ginse-nosides in humans after oral administration. Drug Metab. Dispos. 31: 1065-1071, 2003.
26. Wang, C.Z., S.R. Mehendale and C.S. Yuan. Commonly used antioxidant botanicals: active constituents and their potential role in cardiovascular illness. Am. J. Chin. Med. 35: 543-558, 2007.
27. Wang, C.Z., J.A. Wu, E. McEntee and C.S. Yuan. Saponins composition in American ginseng leaf and berry assayed by high-performance liquid chromatography. J. Agric. Food. Chem. 54: 2261-2266, 2006.
28. Yuan, C.S., G. Wei, L. Dey, T. Karrison, L. Nahlik, S. Maleckar, K. Kasza, M. Ang-Lee and J. Moss. Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled trial. Ann. Intern. Med. 141: 23-27, 2004.